ASPAC II Acquisition Corp. SEC filings ASCRF
ASPAC II Acquisition Corp. has 106 filings in SEC EDGAR's recent list, going back to Aug 10, 2021. Its latest annual report, Form 10-K, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 17, 2025 (material agreement, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Feb 17, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Oct 24, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Oct 11, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Aug 22, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 13, 2023 | Dec 31, 2022 |
Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- ASCBF (OTC), ASCRF (OTC), ASCWF (OTC), ASUUF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Virgin Islands, British
- Headquarters
- Central, Hong Kong
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1876716
- Former names
- SPAC II Acquisition Corp. (until Jun 15, 2022)
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.